KSHV interactions with host nuclear innate response components

KSHV 与宿主核先天反应成分的相互作用

基本信息

  • 批准号:
    10592356
  • 负责人:
  • 金额:
    $ 35.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-08 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Eukaryotic organisms have an array of defense mechanisms to recognize, respond and control the numerous pathogens and harmful substances that they encounter every day. The Innate immune response is one of the first lines of defense to respond and defend in a non-specific manner. KSHV is a sexually transmitted agent in the USA and Western countries, and infects early during life in sub-Saharan Africa. In immune-suppressed individuals, KSHV is etiologically associated with inflammation associated malignancies such as Kaposi’s sarcoma (KS), primary effusion B-cell lymphoma (PEL), and Multicentric Castleman’s disease (MCD). Cytokines such as IL-1β, TNF-α, IFN-γ and IL-6 as well as viral gene products are proposed to drive KS, PEL and MCD development and progression. KSHV infection of endothelial cells induces inflammatory cytokines and growth factors which are similar to the microenvironments of KS/PEL/MCD lesions. We hypothesize that constant activation of innate PRRs by KSHV could be one of the reasons for the chronic inflammation seen in KS, PEL and MCD lesions. Hence, our overall goals are to define the innate immune response against KSHV and to determine its role in KSHV’s biology. We have shown that the cytokine profiles elicited during de novo KSHV infection of human dermal microvascular endothelial cells are identical to the KS/PEL/MCD lesion microenvironments and pro- inflammatory IL-1β and IL-18 cytokines are secreted in the supernatants. IL-1β and IL-18 pro-forms undergo processing by activated caspase-1. Caspase-1, synthesized as procaspase-1, is auto-catalytically cleaved by the molecular platform “inflammasome” that is formed by a sensor protein sensing the danger signal, adaptor molecule ASC and procaspase-1. Whether innate responses recognize and respond to the extra-chromosomal ds-circular KSHV genome (and other DNA viruses) in the nuclei were not known. Our studies for the first time demonstrated that IFI16, a highly conserved nuclear protein involved in transcription by unknown mechanism, is an innate nuclear sensor of KSHV, EBV and HSV-1 genomes. Follow up studies have revealed that IFI16 plays a role in latency maintenance of KSHV. Based on these studies we have extended our original hypothesis and hypothesize that "IFI16 is in complex with different proteins in the nucleus to mediate different functions including innate sensing of episomal DNA and KSHV utilizes/subverts IFI16 and its associated proteins for its latency". Our exciting preliminary studies supports this hypothesis. To test this hypothesis, we have formulated two major focused and interlinked specific aims. These studies are significant since elucidating the role of IFI16 and its associated proteins in the nucleus in KSHV’s latency will allow a deeper understanding of its pathogenesis which will facilitate therapeutic manipulation of this pathway to control KSHV infection, inflammation and the associated malignancies.
真核生物有一系列的防御机制来识别,响应和控制 他们每天都会遇到许多病原体和有害物质。先天免疫反应是 第一道防线之一,以非特定的方式做出反应和防御。KSHV是一种 在美国和西方国家传播病原体,并在撒哈拉以南非洲的生命早期感染。在 在免疫抑制的个体中,KSHV在病因学上与炎症相关的恶性肿瘤相关 如卡波西肉瘤(KS)、原发性渗出性B细胞淋巴瘤(PEL)和多中心Castleman肉瘤 疾病(MCD)。细胞因子如IL-1β、TNF-α、IFN-γ和IL-6以及病毒基因产物被提议用于 推动KS、PEL和MCD的发展和进步。KSHV感染内皮细胞诱导 与KS/PEL/MCD病变微环境相似的炎性细胞因子和生长因子。 我们推测KSHV对先天性PRRs的持续激活可能是慢性炎症的原因之一。 在KS、PEL和MCD病变中观察到炎症。因此,我们的总体目标是定义先天免疫 对KSHV的反应,并确定其在KSHV的生物学作用。 我们已经证明,在KSHV从头感染人皮肤时, 微血管内皮细胞与KS/PEL/MCD病变微环境相同, 炎性IL-1β和IL-18细胞因子分泌到上清液中。IL-1β和IL-18前体形式经历 由活化的caspase-1处理。半胱天冬酶-1,合成为半胱天冬酶原-1,被 分子平台“炎性小体”,其由感测危险信号的传感器蛋白、适配器 分子ASC和半胱氨酸天冬氨酸蛋白酶原-1。先天反应是否识别并响应染色体外的 双环状KSHV基因组(和其他DNA病毒)在细胞核中是未知的。我们的研究首次 证明了IFI 16,一种通过未知机制参与转录的高度保守的核蛋白, 是KSHV、EBV和HSV-1基因组的先天性核传感器。后续研究显示,IFI 16 在KSHV的延迟维持中起作用。基于这些研究,我们扩展了我们原来的 假设和假设“IFI 16与细胞核中的不同蛋白质复合,以介导不同的 包括附加体DNA的先天感应的功能和KSHV利用/破坏IFI 16及其相关的 蛋白质的潜伏期”。我们令人兴奋的初步研究支持这一假设。为了验证这个假设,我们 制定了两个重点突出、相互关联的具体目标。这些研究意义重大,因为 阐明IFI 16及其相关蛋白在KSHV潜伏期细胞核中的作用将使我们能够更深入地了解KSHV的潜伏期。 了解其发病机制,这将有助于治疗操纵这一途径,以控制KSHV 感染、炎症和相关的恶性肿瘤。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
BRCA1 Regulates IFI16 Mediated Nuclear Innate Sensing of Herpes Viral DNA and Subsequent Induction of the Innate Inflammasome and Interferon-β Responses.
  • DOI:
    10.1371/journal.ppat.1005030
  • 发表时间:
    2015-06
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Dutta D;Dutta S;Veettil MV;Roy A;Ansari MA;Iqbal J;Chikoti L;Kumar B;Johnson KE;Chandran B
  • 通讯作者:
    Chandran B
Histone H2B-IFI16 Recognition of Nuclear Herpesviral Genome Induces Cytoplasmic Interferon-β Responses.
组蛋白 H2B-IFI16 识别核疱疹病毒基因组诱导细胞质干扰素-β反应
  • DOI:
    10.1371/journal.ppat.1005967
  • 发表时间:
    2016-10
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Iqbal J;Ansari MA;Kumar B;Dutta D;Roy A;Chikoti L;Pisano G;Dutta S;Vahedi S;Veettil MV;Chandran B
  • 通讯作者:
    Chandran B
Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-β Responses.
  • DOI:
    10.1371/journal.ppat.1005019
  • 发表时间:
    2015-07
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Ansari MA;Dutta S;Veettil MV;Dutta D;Iqbal J;Kumar B;Roy A;Chikoti L;Singh VV;Chandran B
  • 通讯作者:
    Chandran B
IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications.
  • DOI:
    10.1371/journal.ppat.1004503
  • 发表时间:
    2014-11
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Johnson KE;Bottero V;Flaherty S;Dutta S;Singh VV;Chandran B
  • 通讯作者:
    Chandran B
Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
卡波西肉瘤相关疱疹病毒感染诱导内皮细胞神经内分泌基因的表达。
  • DOI:
    10.1128/jvi.01692-19
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    ValiyaVeettil,Mohanan;Krishna,Gayathri;Roy,Arunava;Ghosh,Anandita;Dutta,Dipanjan;Kumar,Binod;Chakraborty,Sayan;Anju,ThoppilRaveendran;Sharma-Walia,Neelam;Chandran,Bala
  • 通讯作者:
    Chandran,Bala
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bala Chandran其他文献

Bala Chandran的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bala Chandran', 18)}}的其他基金

KSHV interactions with host nuclear innate response components
KSHV 与宿主核先天反应成分的相互作用
  • 批准号:
    10375451
  • 财政年份:
    2019
  • 资助金额:
    $ 35.51万
  • 项目类别:
KSHV interactions with host nuclear innate response components
KSHV 与宿主核先天反应成分的相互作用
  • 批准号:
    9910368
  • 财政年份:
    2019
  • 资助金额:
    $ 35.51万
  • 项目类别:
Interferon gamma inducible protein 16 and KSHV gene expression
干扰素γ诱导蛋白16和KSHV基因表达
  • 批准号:
    8769399
  • 财政年份:
    2014
  • 资助金额:
    $ 35.51万
  • 项目类别:
KSHV interactions with host inflammasome components
KSHV 与宿主炎症小体成分的相互作用
  • 批准号:
    8731458
  • 财政年份:
    2014
  • 资助金额:
    $ 35.51万
  • 项目类别:
KSHV interactions with host inflammasome components
KSHV 与宿主炎症小体成分的相互作用
  • 批准号:
    9532411
  • 财政年份:
    2014
  • 资助金额:
    $ 35.51万
  • 项目类别:
Conference Support for 16th International Workshop on KSHV and Related Agents, Pu
第 16 届 KSHV 及相关药物国际研讨会会议支持,浦
  • 批准号:
    8541332
  • 财政年份:
    2013
  • 资助金额:
    $ 35.51万
  • 项目类别:
Early events of in vitro KSHV infection
体外 KSHV 感染的早期事件
  • 批准号:
    8446318
  • 财政年份:
    2012
  • 资助金额:
    $ 35.51万
  • 项目类别:
Early events of in vitro KSHV infection
体外 KSHV 感染的早期事件
  • 批准号:
    8616737
  • 财政年份:
    2012
  • 资助金额:
    $ 35.51万
  • 项目类别:
HHV-8, angiogenesis and inflammation
HHV-8、血管生成和炎症
  • 批准号:
    8337885
  • 财政年份:
    2011
  • 资助金额:
    $ 35.51万
  • 项目类别:
Entry of HHV-8 Into the Target Cells
HHV-8 进入靶细胞
  • 批准号:
    7388885
  • 财政年份:
    2005
  • 资助金额:
    $ 35.51万
  • 项目类别:

相似海外基金

ESE: Collaborative Research: Climate Change and Variability and Armed Conflicts in Africa South of the Sahara
ESE:合作研究:撒哈拉以南非洲的气候变化和变异性以及武装冲突
  • 批准号:
    0964515
  • 财政年份:
    2010
  • 资助金额:
    $ 35.51万
  • 项目类别:
    Standard Grant
Network Dynamics, Sexual Behaviour, and HIV Among University Students in Africa South of the Sahara
撒哈拉以南非洲大学生的网络动态、性行为和艾滋病毒
  • 批准号:
    178094
  • 财政年份:
    2008
  • 资助金额:
    $ 35.51万
  • 项目类别:
    Studentship Programs
Synopsis of Ichneumoniae of Africa, South of the Sahara
撒哈拉以南非洲的姬蜂病简介
  • 批准号:
    66B2956
  • 财政年份:
    1966
  • 资助金额:
    $ 35.51万
  • 项目类别:
To Attend Synopsis of Ichneumoninae of Africa, South of the Sahara
参加撒哈拉以南非洲的姬蜂亚科概要
  • 批准号:
    65B2956
  • 财政年份:
    1965
  • 资助金额:
    $ 35.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了